This project was conceived in 1994 to help increase the number and percentage of drugs which are labeled for pediatric use (currently approximately 75 percent are not labeled for pediatric use) and to increase the knowledge of clinical pharmacology that is so important to intelligent, safe drug use in infants and children. The scope of the PPRU grant is to provide an organizational and operational infrastructure at UCSD and Children's Hospital of San Diego to implement the following specific aims: 1. To provide a locus for the conduct of studies in bioavailability, formulations, drug metabolism, pharmacokinetics, pharmacodynamics, safety and effectiveness of new drugs and drugs already in the market. These studies may be investigator initiated or they may originate with pharmaceutical companies or Contract Research Organizations (CRO's). 2. To gather or promote the accrual of the necessary clinical data for pediatric age-specific labeling of drugs. 3. To conduct research on new pediatric therapeutic modalities, including: A. Molecular approaches to the treatment of diseases, B. Application of new technology to pharmacodynamic studies and drug delivery systems, and C. Development of pediatric formulations, and d) validation of new endpoints or surrogate markers. 4. To conduct studies on the developmental characteristics and genetic polymorphism of drug metabolizing enzymes, pharmacokinetic modeling, and simulation technology. 5. To provide a teaching environment in which pediatricians, pharmacists, nurses and others can gain supervised experience in pediatric clinical trials and training in evidence-based pediatric pharmacology.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Research Project--Cooperative Agreements (U01)
Project #
2U01HD031318-06
Application #
2756793
Study Section
Special Emphasis Panel (ZHD1-DRG-H (02))
Project Start
1994-01-01
Project End
2003-12-31
Budget Start
1999-01-07
Budget End
1999-12-31
Support Year
6
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of California San Diego
Department
Pediatrics
Type
Schools of Medicine
DUNS #
077758407
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Aweeka, F T; Hu, C; Huang, L et al. (2015) Alteration in cytochrome P450 3A4 activity as measured by a urine cortisol assay in HIV-1-infected pregnant women and relationship to antiretroviral pharmacokinetics. HIV Med 16:176-83
Best, Brookie M; Capparelli, Edmund V; Diep, Huy et al. (2011) Pharmacokinetics of lopinavir/ritonavir crushed versus whole tablets in children. J Acquir Immune Defic Syndr 58:385-91
Aweeka, F T; Stek, A; Best, B M et al. (2010) Lopinavir protein binding in HIV-1-infected pregnant women. HIV Med 11:232-8
Read, J S; Best, B M; Stek, A M et al. (2008) Pharmacokinetics of new 625 mg nelfinavir formulation during pregnancy and postpartum. HIV Med 9:875-82
Shapiro, Roger L; Holland, Diane T; Capparelli, Edmund et al. (2005) Antiretroviral concentrations in breast-feeding infants of women in Botswana receiving antiretroviral treatment. J Infect Dis 192:720-7
Lemire, J; Capparelli, E V; Benador, N et al. (2001) Neoral pharmacokinetics in Latino and Caucasian pediatric renal transplant recipients. Pediatr Nephrol 16:311-4
Lemire, J; Capparelli, E V; MacDonald, D et al. (1998) Estimated area-under-the-curve monitoring of Neoral in a stable pediatric renal transplant population: one-year experience. Transplant Proc 30:1983-4